Skip to content

PressReach

SEARCH

Investing
Featured
Market
Biotech
Oil & Gas
Mining
Gaming
Tech
Crypto
More

Search

SEARCH FOR AN ARTICLE

Search

Investing
Featured
Market
Biotech
Oil & Gas
Mining
Gaming
Tech
Crypto
More

PressReach

HomeNASDAQ:IRIX

NASDAQ:IRIX

Iridex stock declines 7% as Stifel predicts modest volume growth for the glaucoma system

Iridex stock declines 7% as Stifel predicts modest volume growth for the glaucoma system

August 26, 2022

LATEST NEWS

Investing News Buffett’s Apple Investments Grow
Investing News Wayfair Faces Customer Decline
Investing News Amazon Q3 FY 2024 Earnings Preview
Investing News Atlassian’s Stock Soars After Impressive Results
Investing News Cardinal Health Stock Reaches New Heights

PressReach

All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

Advertisers
Privacy Policy
Terms of Use
DMCA Policy
Disclaimer
Contact Us

SUBSCRIBE

To get email updates from PressReach.

I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

Market Jar Media Inc. © 2024